Quality of life and symptom burden in patients with end-stage kidney disease receiving home peritoneal dialysis: a systematic review
Review of Clinical Pharmacology and Pharmacokinetics · 12.11.2026 · 40 · 63-77
DOI: 10.61873/rcpp.40.e201251 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Review of Clinical Pharmacology and Pharmacokinetics, online erschienen am 12.11.2026. Verfasst von Sotiroulla Konstantinou Glyky und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Home-based peritoneal dialysis (PD) offers autonomy and flexibility but may involve multidimensional patient-reported burden.
Aim
To synthesize evidence on psychological, symptom-related, social, socioeconomic, and practical burden among adults receiving home-based PD. Methodology: Searches were conducted from December 2025 to April 2026 using PubMed and targeted nephrology/nursing sources and updated on 9 September 2026 using CINAHL Plus with Full Text and APA PsycINFO. Primary studies reporting patient perspectives or outcomes relevant to PD or home dialysis were included. PRISMA 2020 guided reporting. Methodological appraisal used the Appraisal Tool for Cross-Sectional Studies (AXIS), the Critical Appraisal Skills Programme (CASP) Qualitative Studies Checklist, the Newcastle–Ottawa Scale (NOS), and the Cochrane Risk of Bias 2 (RoB 2) tool, according to study design.
Results
Thirteen studies were included: six cross-sectional, two prospective cohort, four qualitative, and one randomized controlled trial. Findings identified psychological distress, symptom burden, coping and adaptation challenges, and social, socioeconomic, relational, and practical demands. Quality of life was associated with individual, social, socioeconomic, and treatment-related factors. Broader dialysis evidence was treated as contextual when PD-specific findings could not be distinguished.
Conclusion
Home-based PD may involve interacting multidimensional burdens. Comprehensive, patient-centred care and further PD-specific research are needed. These burdens may also be clinically relevant to medication self-management and individualized pharmacological care.
Zitieren
APA
Glyky, S. K., Noula, M., Frangou, E., & Roupa, Z. (2026). Quality of life and symptom burden in patients with end-stage kidney disease receiving home peritoneal dialysis: a systematic review. Review of Clinical Pharmacology and Pharmacokinetics, 40, 63-77. https://doi.org/10.61873/rcpp.40.e201251
Vancouver
Glyky SK, Noula M, Frangou E, Roupa Z. Quality of life and symptom burden in patients with end-stage kidney disease receiving home peritoneal dialysis: a systematic review. Review of Clinical Pharmacology and Pharmacokinetics. 2026;40:63-77. doi:10.61873/rcpp.40.e201251
BibTeX
@article{Glyky2026,
author = {Glyky, Sotiroulla Konstantinou and Noula, Maria and Frangou, Eleni and Roupa, Zoe},
title = {Quality of life and symptom burden in patients with end-stage kidney disease receiving home peritoneal dialysis: a systematic review},
journal = {Review of Clinical Pharmacology and Pharmacokinetics},
year = {2026},
volume = {40},
pages = {63--77},
doi = {10.61873/rcpp.40.e201251}
}
EUVIMED